Peer-reviewedLicence not statedNanomedicine
Evaluation of a bismuth-ellagic acid metal-organic framework for the prophylaxis of inflammatory disorders
- 1Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu, China
- 2Department of Pharmacy, Jinan Vocational College of Nursing, Jinan, Shandong, China
Related
- Evaluation of novel 1,4-dihydropyridine spirooxindole as antitumor, anti-inflammatory, and antioxidant agents
- Comparative Anti-Inflammatory Evaluation of Lamiaceae Essential Oils and Mechanistic Insights into Mentha haplocalyx Essential Oil via Network Pharmacology and Molecular Dynamics
- Cyclic ester insertion into a bismuth–amide bond: isolable molecular models for ROP initiation
- A Nano-Bismuth–Silicone Polymer Composite as Shielding for X-Rays in Extreme-Environment Applications: Experimental and Simulation Studies
- Synthesis, X-ray structures and biological evaluation of novel α-aminophosphonate derivatives as anti-inflammatory and antioxidant agents: an integrated in vitro and in silico study
BibTeX
@article{huang2026evaluation,
title = {{Evaluation of a bismuth-ellagic acid metal-organic framework for the prophylaxis of inflammatory disorders}},
author = {Xiuxiu Huang and Meizhen He and Yuqi Fang and Nan Hu and Xiaoyu Wang and Yinan Wang},
journal = {Nanomedicine},
year = {2026},
month = oct,
doi = {10.1080/17435889.2026.2750966},
url = {https://doi.org/10.1080/17435889.2026.2750966},
}
RIS
TY - JOUR
TI - Evaluation of a bismuth-ellagic acid metal-organic framework for the prophylaxis of inflammatory disorders
AU - Xiuxiu Huang
AU - Meizhen He
AU - Yuqi Fang
AU - Nan Hu
AU - Xiaoyu Wang
AU - Yinan Wang
PY - 2026
DA - 2026/10/22
JO - Nanomedicine
DO - 10.1080/17435889.2026.2750966
UR - https://doi.org/10.1080/17435889.2026.2750966
SN - 1743-5889
SN - 1748-6963
ER -